<PAGE> 1
\ SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D. C. 20549
SCHEDULE 13D
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. 1)
COMMUNITY MEDICAL TRANSPORT, INC.
- --------------------------------------------------------------------------------
(Name of Issuer)
Common Stock, $ 0.001 par value
- --------------------------------------------------------------------------------
(Title of Class of Securities)
203744107
- --------------------------------------------------------------------------------
(CUSIP Number)
Thomas A. Huser, Esq.
Quadrant Management, Inc.
720 5th Avenue, 9th Floor
New York, New York 10019
212-231-3900
- --------------------------------------------------------------------------------
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
November 4, 1998
- --------------------------------------------------------------------------------
(Date of Event which Requires Filing
of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition which is the subject of this Schedule 13D, and is filing this
schedule because of
Rule 13d-1 (b)(3) or (4), check the following box [ ] .
Check the following box if a fee is being paid with this statement [ ] .
(Continued on following page (s)
Page 1 of 7 Pages
Exhibit Index Appears on Page 5)
<PAGE> 2
CUSIP NO. 203744107 13D Page 2 of 7 Pages
1 NAME OF REPORTING PERSON
SSN OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Herbard Limited (no Fed. I.D. No.)
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER (a) [ ]
OF A GROUP. (b) [ ]
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 SOURCE OF FUNDS WC
- --------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS [ ]
IS REQUIRED PURSUANT TO ITEMS 2 (d) or 2 (e)
- --------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION British Virgin Islands
- --------------------------------------------------------------------------------
NUMBER 7 SOLE VOTING POWER 463,400 Shares
OF -----------------------------------------------------------
WARRANTS
BENEFICIALLY 8 SHARED VOTING POWER NONE
OWNED -----------------------------------------------------------
BY
EACH 9 SOLE DISPOSITIVE POWER 463,400 Shares
REPORTING -----------------------------------------------------------
PERSON
WITH 10 SHARED DISPOSITIVE POWER NONE
- --------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
PERSON 463,400 Shares
- --------------------------------------------------------------------------------
12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES [ ]
CERTAIN SHARES
- --------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 7.73%
- --------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON CO
- --------------------------------------------------------------------------------
<PAGE> 3
CUSIP NO. 203744107 13D Page 3 of 7 pages
Item 1 SECURITY AND ISSUER
This statement on Schedule 13D (the "Amendment"),
filed with respect to events that occurred on November 4, 1998, relates to
shares of Common Stock, par value $0.001 per share, of Community Medical
Transport, Inc., a Delaware corporation (the "Common Stock" and the "Issuer",
respectively), whose principal executive offices are located at 4 Gannett Drive,
White Plains, New York, 10604.
Item 2 IDENTITY AND BACKGROUND
This Statement is filed by Herbard Limited, a British
Virgin Islands corporation ("Herbard").
Herbard may be deemed to be controlled by the Phyllis
Quasha Revocable Trust. Phyllis G. Quasha, as the settlor of the Trust, may be
deemed to control the Trust. Based upon the foregoing considerations, for
purposes of General Instruction C to Schedule 13D, the Phyllis Quasha Revocable
Trust and Phyllis G. Quasha (collectively, the "Instruction C Persons") may be
deemed to control Herbard.
Exhibit A sets forth the name, place of organization,
principal business, address of principal business and address of principal
office of Herbard and each Instruction C Person.
The name, citizenship, business address and present
principal occupation or employment of each executive officer and director of
Herbard and each of the Instruction C Persons, as well as the name, principal
business and address of the corporation or other organization in which such
occupation or employment is conducted, are set forth in Exhibit B.
During the five years prior to the date hereof,
neither Herbard nor, to the best of their knowledge, any of the Instruction C
Persons or any executive officer or director of Herbard or any of the
Instruction C Persons, (i) have been convicted in a criminal proceeding
(excluding traffic violations or similar misdemeanors) or (ii) has been a party
to a civil proceeding of a judicial or administrative body of competent
jurisdiction, as a result of which such person was or is subject to a judgment,
decree or final order enjoining future violations of, or prohibiting or
mandating activities subject to, federal or state securities laws or finding any
violation with respect to such laws.
Item 3 SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION
The funds for purchase by Herbard of the 95,200
shares of Common Stock purchased from October 6 through November 4, 1998, an
aggregate of $56,773.74, came from the general corporate funds of Herbard.
<PAGE> 4
CUSIP NO. 203744107 13D Page 4 of 7 Pages
Item 4 PURPOSE OF THE TRANSACTION
From October 6 though October 15, 1998, Herbard
purchased an aggregate of 95,200 shares of Common Stock in transactions in the
over-the-counter market, as part of its short-term trading and long-term
investment activities. Those transactions are set forth in more detail in
Exhibit E hereto.
Item 5 INTEREST IN SECURITIES OF THE ISSUER
(a) & (b) As of August 6, 1998, the Issuer had a
total of 5,994,000 shares of Common Stock issued and outstanding according to
information made publicly available by the Issuer.
Pursuant to Rule 13d-3, the Reporting Person may be
deemed to beneficially own an aggregate of 463,400 Shares. Pursuant to Rule
13d-3 (d) (1) (i), such 463,400 Shares constitute an aggregate of approximately
7.73% of the outstanding Common Stock.
(c) Other than the transactions described in this
Statement as amended, no transactions in the shares of Common Stock have been
effected during the past 60 days by Herbard, or, any of the persons named in
Exhibit B.
(d) Inapplicable
(e) Inapplicable
Item 6 Contracts, Arrangements, Understandings or Relationships with
respect to Securities of the Issuer.
Neither Herbard nor, to the best of its knowledge, any executive
officer or director thereof, has any contract, arrangement, understanding or
relationship with one or more security holders of the Issuer or others, with
respect to the purchase, holding, voting or disposition of shares of Common
Stock or other securities of the Issuer which are convertible or exercisable
into such shares. Each of such persons reserves the right to enter into any such
contract, arrangement, understanding or relationship in the future.
<PAGE> 5
CUSIP NO. 203744107 13D Page 5 of 7 Pages
<TABLE>
<CAPTION>
Item 7 Material to be Filed as Exhibits Page
-------------------------------- ----
<S> <C>
Exhibit A: Information concerning Previously filed
Reporting Persons and Instruction C Persons.
Exhibit B: Information concerning Previously filed
Reporting Persons' and Instruction C Persons' Officers, Directors and Others.
Exhibit C: Power of Attorney of Previously filed
Herbard Limited granted to Thomas A. Huser.
Exhibit D: Information concerning Previously filed
other shares purchased within the last 60 days.
Exhibit E: Information concerning 7
shares purchased October 6 though November 4, 1998.
</TABLE>
<PAGE> 6
CUSIP NO. 203744107 13D Page 6 of 7 Pages
SIGNATURES
After reasonable inquiry and to the best of its knowledge and
belief, the undersigned certifies that the information set forth in this
statement is true, complete and correct.
Dated: November 6, 1998
HERBARD LIMITED
By: /s/ Thomas A. Huser
------------------------
Thomas A. Huser
Attorney-in-Fact
<PAGE> 1
CUSIP NO. 203744107 13D Page 7 of 7 Pages
EXHIBIT E
PURCHASES OF SHARES OCTOBER 6 THROUGH NOVEMBER 4, 1998
<TABLE>
<CAPTION>
Date Number of Shares Price Per Share
- ---- ---------------- ---------------
<S> <C> <C>
10/06/98 60,000 $.62
10/07/98 10,000 $.60
10/14/98 8,000 $.50
10/15/98 10,200 $.53
11/04/98 7,000 $.4955
</TABLE>
